Stock Research: Ono Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Ono Pharmaceutical

TSE:4528 JP3197600004
71
  • Value
    65
  • Growth
    30
  • Safety
    Safety
    86
  • Combined
    72
  • Sentiment
    63
  • 360° View
    360° View
    71
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company that manufactures and sells pharmaceuticals. The company operates in the pharmaceutical industry. ONO PHARMACEUTICAL CO., LTD. operates primarily in Japan. In the last fiscal year, the company had a market cap of $5,561 million, profits of $2,260 million, revenue of $3,247 million, and 4287 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock Ono Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Ono Pharmaceutical. The consolidated Value Rank has an attractive rank of 86, which means that the share price of Ono Pharmaceutical is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 86% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 65. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 63. But the consolidated Growth Rank has a low rank of 30, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 70 of its competitors have better growth. ...read more

more
Index
TOPIX 100
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 94 84 65
Growth
30 22 11 57
Safety
Safety
65 95 90 82
Sentiment
63 6 32 31
360° View
360° View
71 61 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
3 1 5 41
Opinions Change
72 35 50 40
Pro Holdings
n/a 10 70 82
Market Pulse
64 46 44 12
Sentiment
63 6 32 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 94 84 65
Growth
30 22 11 57
Safety Safety
65 95 90 82
Combined
72 89 75 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
80 88 100 89
Price vs. Earnings (P/E)
52 69 41 39
Price vs. Book (P/B)
72 88 62 61
Dividend Yield
91 91 89 77
Value
86 94 84 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
6 41 10 76
Profit Growth
78 4 54 52
Capital Growth
17 79 32 17
Stock Returns
66 8 19 55
Growth
30 22 11 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
53 83 85 80
Refinancing
58 73 51 39
Liquidity
70 97 98 96
Safety Safety
65 95 90 82

Similar Stocks

Discover high‑ranked alternatives to Ono Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Sankyu

TSE:9065
Country: Japan
Industry: Trucking
Size: Medium
Full Stock Analysis

Stanley Electric

TSE:6923
Country: Japan
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.